186 related articles for article (PubMed ID: 25636111)
1. [Association of T190C polymorphism of β3 adrenergic receptor gene with response to carvedilol in patients with chronic heart failure].
Yu H; Wei F; Qian G; Li L; Zhang C; Cheng Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Feb; 32(1):101-4. PubMed ID: 25636111
[TBL] [Abstract][Full Text] [Related]
2. [Beta1-adrenergic receptor (Arg389Gly) polymorphism and response to bisoprolol in patients with chronic heart failure].
Yu WP; Lou M; Deng B; Song HM; Wang HB
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):776-80. PubMed ID: 17217681
[TBL] [Abstract][Full Text] [Related]
3. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
[TBL] [Abstract][Full Text] [Related]
4. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L
Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314
[TBL] [Abstract][Full Text] [Related]
5. [Impact of Gly389Arg beta1-adrenoceptor polymorphism on the risk of chronic heart failure, the nature of its course, and on the efficiency of its treatment with carvedilol].
Tepliakov AT; Shilov SN; Berezikova EN; Torim IuIu; Efremov AV; Safronov ID; Maianskaia SD; Popova AA; Voronina EN; Karpov RS
Ter Arkh; 2010; 82(12):22-8. PubMed ID: 21516734
[TBL] [Abstract][Full Text] [Related]
6. Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure.
Mortara A; La Rovere MT; Pinna GD; Maestri R; Capomolla S; Cobelli F
J Am Coll Cardiol; 2000 Nov; 36(5):1612-8. PubMed ID: 11079666
[TBL] [Abstract][Full Text] [Related]
7. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
[TBL] [Abstract][Full Text] [Related]
8. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
9. The effect of carvedilol on B-type natriuretic peptide and cardiac function in patients with heart failure and persistent atrial fibrillation.
Khand AU; Chew PG; Douglas H; Jones J; Jan A; Cleland JG
Cardiology; 2015; 130(3):153-8. PubMed ID: 25660493
[TBL] [Abstract][Full Text] [Related]
10. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.
Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S
Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827
[TBL] [Abstract][Full Text] [Related]
11. Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study.
Lee HY; Chung WJ; Jeon HK; Seo HS; Choi DJ; Jeon ES; Kim JJ; Shin JH; Kang SM; Lim SC; Baek SH
Korean J Intern Med; 2016 Mar; 31(2):277-87. PubMed ID: 26879662
[TBL] [Abstract][Full Text] [Related]
12. Effects of carvedilol on heart rate dynamics in patients with congestive heart failure.
Ridha M; Mäkikallio TH; Lopera G; Pastor J; de Marchena E; Chakko S; Huikuri HV; Castellanos A; Myerburg RJ
Ann Noninvasive Electrocardiol; 2002 Apr; 7(2):133-8. PubMed ID: 12049685
[TBL] [Abstract][Full Text] [Related]
13. Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure.
de Groote P; Helbecque N; Lamblin N; Hermant X; Mc Fadden E; Foucher-Hossein C; Amouyel P; Dallongeville J; Bauters C
Pharmacogenet Genomics; 2005 Mar; 15(3):137-42. PubMed ID: 15861037
[TBL] [Abstract][Full Text] [Related]
14. Gln(27)-->Glubeta(2)-adrenergic receptor polymorphism in heart failure patients: differential clinical and oxidative response to carvedilol.
Troncoso R; Moraga F; Chiong M; Roldán J; Bravo R; Valenzuela R; Díaz-Araya G; del Campo A; Sanhueza C; Rodriguez A; Vukasovic JL; Mellado R; Greig D; Castro PF; Lavandero S
Basic Clin Pharmacol Toxicol; 2009 May; 104(5):374-8. PubMed ID: 19422106
[TBL] [Abstract][Full Text] [Related]
15. [Serum autoantibodies against the cardiac beta(1)-adrenergic receptor in patients with chronic heart failure: clinical characteristics and response to carvedilol].
Chen J; Yang XC; Wang SY; Zhu JG; Liu XL; Wu YF; Zhang L
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):599-602. PubMed ID: 17961421
[TBL] [Abstract][Full Text] [Related]
16. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
[TBL] [Abstract][Full Text] [Related]
17. Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure.
Kaye DM; Smirk B; Williams C; Jennings G; Esler M; Holst D
Pharmacogenetics; 2003 Jul; 13(7):379-82. PubMed ID: 12835612
[TBL] [Abstract][Full Text] [Related]
18. Carvedilol: a review of its use in chronic heart failure.
Keating GM; Jarvis B
Drugs; 2003; 63(16):1697-741. PubMed ID: 12904089
[TBL] [Abstract][Full Text] [Related]
19. Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure.
Razzolini R; Tarantini G; Boffa GM; Orlando S; Iliceto S
Ital Heart J; 2004 Jul; 5(7):517-22. PubMed ID: 15487269
[TBL] [Abstract][Full Text] [Related]
20. Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure.
Palazzuoli A; Quatrini I; Vecchiato L; Scali C; De Paola V; Iovine F; Martini G; Nuti R
Minerva Cardioangiol; 2005 Aug; 53(4):321-8. PubMed ID: 16177676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
